Ronit Heinrich
Ami Aronheim
Yung-Chih Cheng
Ido Perlman- 1Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
- 2Emerging Science and Innovation, Worldwide Research, Pfizer Cambridge, Cambridge, MA, United States
Editorial on the Research Topic
ATF3: a crucial stress-responsive gene of glia and neurons in CNS
The central nervous system (CNS) is a highly complex and sensitive structure that responds dynamically to various stressors, including physical injuries (Weil et al., 2008), psychological stress (Pavlovsky et al., 2013), and neuroinflammatory conditions (Förstner et al., 2018). Within this complicated system, transcription factors play pivotal roles in modulating gene expression in response to different stressors, with Activating Transcription Factor 3 (ATF3) emerging as a crucial player in the CNS response to stress (Anderson, 2012). This editorial emphasizes the significance of ATF3 in CNS stress, highlighting recent research findings and their implications for neurological health and disease.
ATF3 is a member of the ATF/cAMP responsive element-binding (CREB) protein family and is widely recognized as a stress-inducible gene (Hai et al., 1999). It is rapidly upregulated in response to various stress signals, including axonal injury (Wong et al., 2018), oxidative stress (Okamoto et al., 2006), ischemia (Kao et al., 2023), metabolic stress (Ku and Cheng, 2020) and mechanical injury (Wong et al., 2018; Lou et al., 2023).
Recently, ATF3 was shown to be induced specifically in neurons of the spinal cord or cortex within 1 day after spinal cord injury (SCI) or ischemic stroke in mice (Kao et al., 2023; Pan et al., 2024). Additionally, ATF3 protein levels in mouse blood significantly increased 1 day after SCI as well as after ischemic stroke (Pan et al., 2024). Most importantly, ATF3 protein levels in human serum were elevated in patients within 24 h after SCI or ischemic stroke (Pan et al., 2024). These results demonstrate the feasibility of using ATF3 level in patients' serum as a potential biomarker for CNS trauma (Pan et al., 2024).
One of the primary contexts in which ATF3 has been studied is neuronal injury (Tsujino et al., 2000). Following axonal damage, ATF3 expression is markedly increased in affected neurons, which is believed to contribute to the cellular response aimed at repair and regeneration (Petrović et al., 2022). For instance, in models of peripheral nerve injury, ATF3 has been shown to promote neurite outgrowth and to enhance the intrinsic growth capacity of neurons (reviewed in Katz et al., 2022). Comparing RNA expression data across species that exhibit different abilities to regenerate their nervous system following traumatic nerve injury reveals that ATF3 is consistently induced in neurons within the first few days after injury. Thus, ATF3 can definitely be considered as an evolutionary conserved regulator of neuronal regeneration (Katz et al., 2022).
ATF3 also modulates the response of the CNS to inflammation and psychological stress. In conditions of neuroinflammation, such as those observed in multiple sclerosis and other neurodegenerative diseases, ATF3 expression is upregulated in glial cells (reviewed in Anderson, 2012), including astrocytes and microglia. This upregulation is associated with the modulation of inflammatory responses (Hai et al., 2018), which can be either protective or detrimental depending upon the context and duration of the stressor. It has been mentioned that targeting microglial ATF3 upregulation to mitigate inflammation would be an interesting and necessary therapeutic avenue across a range of CNS disease (Holland and Ramer). Regarding cell death, ATF3 has been reported to be either pro-apoptotic or anti-apoptotic. For instance, the neuroinflammatory response during Alzheimer disease (AD) is triggered by microglia secreting pro-inflammatory cytokines, including CCL4, which attracts astrocytes to encapsulate plaques. Noteworthy, CCL4 is undetectable in normal brain, however, it is significantly present in AD brain at increased concentrations and is positively correlated with amyloid deposition. As ATF3 was found to bind to the promoter region of the CCL4 gene and to positively regulate its transcription, it was concluded that AD progression is controlled also by ATF3 which regulates the associated neuroinflammation pathways (reviewed in Yang et al., 2023). In another study of a mouse model of Parkinson's diseases, ATF3-knockdown decreased CHOP (C/EBP-homologous protein) and cleaved caspase-3 levels (apoptotic markers), suggesting that ATF3 plays a role in apoptosis induction (Zhao et al., 2016). Additionally, in response to lipotoxic brain microvascular damage, ATF3 was found to mainly govern triglyceride-rich lipoprotein-induced inflammation and TNF signaling in the cerebrovascular system and increase endothelial cell apoptosis (Nyunt et al., 2019). However, in ischemic stroke, ATF3 overexpression attenuated neuronal caspase-dependent apoptosis, microglial activation, and pro-inflammatory cytokine production to alleviate brain injury. ATF3 was also shown to reduce microglia activation and, by doing so, to prevent apoptosis. In addition, ATF3 was shown to prevent neuronal apoptosis by promoting the expression of the anti-apoptotic neuronal survival factor HSP27 and activation of Akt (reviewed in Li et al., 2023).
Recent studies have explored the role of ATF3 in psychological stress response of the CNS. Chronic stress is known to induce changes in brain function and structure, contributing to mental health disorders like depression and anxiety (Green et al., 2008; Pai et al., 2018). ATF3 appears to be involved in the cellular mechanisms underlying these changes, influencing neuroplasticity and stress resilience.
The multifaceted roles of ATF3 in the CNS suggest that it could become a valuable target for therapeutic interventions aimed at mitigating the effects of CNS stress. For example, enhancing ATF3 expression in neurons might promote recovery after traumatic brain injury or stroke (reviewed in Li et al., 2023). Additionally, modulating ATF3 activity in glial cells could help manage chronic neuroinflammation seen in diseases like Alzheimer's (Yang et al., 2023) and Parkinson's (Yoo et al., 2017).
However, the dual nature of ATF3's actions—promoting repair in some contexts (Seijffers et al., 2006) while potentially exacerbating damage in others (Yang et al., 2023)—necessitates a nuanced approach to therapeutic development. Understanding the precise conditions under which ATF3 exerts its beneficial vs. detrimental effects will be crucial for harnessing its potential in clinical settings.
Conclusion
ATF3 is a pivotal transcription factor in the CNS response to all forms of stress, playing significant roles in neuronal injury repair, neuroinflammation, recovery from metabolic stress, and psychological stress adaptation. Ongoing research continues to unravel the complexities of ATF3 functions, indicating its actions to promote functional tissues repair via two opposing pathways. In some cases, it acts to promote regeneration of damaged tissue while in others it may activate apoptosis of badly damaged cells to prevent spread of damage to non-affected cells in the same tissue. The dual nature of ATF3 actions is highly context dependent. Its effects vary based on the type of stress, the specific tissue or cell type, and the interplay with other signaling pathways. Thus, ATF3 offers promising avenues for therapeutic interventions aimed at enhancing CNS resilience and recovery. As we deepen our understanding of ATF3 roles and mechanisms, we move closer to developing targeted strategies that can attenuate the adverse effects of different types of stress on CNS function and improve outcomes for individuals suffering from neurological disorders.
Author contributions
RH: Writing – original draft, Writing – review & editing. AA: Writing – review & editing. Y-CC: Writing – review & editing. IP: Writing – review & editing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Anderson, P. (2012). Activating transcription factor 3 and the nervous system. Front. Mol. Neurosci. 5:7. doi: 10.3389/fnmol.2012.00007
Förstner, P., Rehman, R., Anastasiadou, S., Haffner-Luntzer, M., Sinske, D., Ignatius, A., et al. (2018). Neuroinflammation after traumatic brain injury is enhanced in activating transcription factor 3 mutant mice. J. Neurotrauma 35, 2317–2329. doi: 10.1089/neu.2017.5593
Green, T. A., Alibhai, I. N., Unterberg, S., Neve, R. L., Ghose, S., Tamminga, C. A., et al. (2008). Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. J. Neurosci. 28, 2025–2032. doi: 10.1523/JNEUROSCI.5273-07.2008
Hai, T., Wolfgang, C. D., Marsee, D. K., Allen, A. E., and Sivaprasad, U. (1999). ATF3 and stress responses. Gene Expr. 7, 321–35.
Hai, T., Wolford, C. C., and Chang, Y.-S. (2018). ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component? Gene Expr. 15, 1–11. doi: 10.3727/105221610X12819686555015
Kao, M. H., Huang, C. Y., Cheung, W. M., Yan, Y. T., Chen, J. J., Ho, Y. S., et al. (2023). Activating transcription factor 3 diminishes ischemic cerebral infarct and behavioral deficit by downregulating carboxyl-terminal modulator protein. Int. J. Mol. Sci. 24:2306. doi: 10.3390/ijms24032306
Katz, H. R., Arcese, A. A., Bloom, O., and Morgan, J. R. (2022). Activating transcription factor 3 (ATF3) is a highly conserved pro-regenerative transcription factor in the vertebrate nervous system. Front. Cell Dev. Biol. 10:824036. doi: 10.3389/fcell.2022.824036
Ku, H.-C., and Cheng, C.-F. (2020). Master regulator activating transcription factor 3 (ATF3) in metabolic homeostasis and cancer. Front. Endocrinol. 11:556. doi: 10.3389/fendo.2020.00556
Li, Y., Fan, Q., Li, F., Pang, R., Chen, C., Li, P., et al. (2023). The multifaceted roles of activating transcription factor 3 (ATF3) in inflammatory responses – potential target to regulate neuroinflammation in acute brain injury. J. Cereb. Blood Flow Metab. 43, 8–17. doi: 10.1177/0271678X231171999
Lou, Y., Song, F., Kang, Y., and Xu, Y. (2023). Periodic mechanical stress inhibits the development of osteoarthritis via regulating ATF3-Akt axis. J. Inflamm. Res. 16, 5613–5628. doi: 10.2147/JIR.S419186
Nyunt, T., Britton, M., Wanichthanarak, K., Budamagunta, M., Voss, J. C., Wilson, D. W., et al. (2019). Mitochondrial oxidative stress-induced transcript variants of ATF3 mediate lipotoxic brain microvascular injury. Free Radic. Biol. Med. 143, 25–46. doi: 10.1016/j.freeradbiomed.2019.07.024
Okamoto, A., Iwamoto, Y., and Maru, Y. (2006). Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Mol. Cell. Biol. 26, 1087–1097. doi: 10.1128/MCB.26.3.1087-1097.2006
Pai, C. S., Sharma, P. K., Huang, H. T., Loganathan, S., Lin, H., Hsu, Y. L., et al. (2018). The activating transcription factor 3 (Atf3) homozygous knockout mice exhibit enhanced conditioned fear and down regulation of hippocampal GELSOLIN. Front. Mol. Neurosci. 11:37. doi: 10.3389/fnmol.2018.00037
Pan, J. Z., Wang, Z., Sun, W., Pan, P., Li, W., Sun, Y., et al. (2024). ATF3 is a neuron-specific biomarker for spinal cord injury and ischaemic stroke. Clin. Transl. Med. 14:e1650. doi: 10.1002/ctm2.1650
Pavlovsky, A. A., Boehning, D., Li, D., Zhang, Y., Fan, X., and Green, T. A. (2013). Psychological stress, cocaine and natural reward each induce endoplasmic reticulum stress genes in rat brain. Neuroscience 246, 160–169. doi: 10.1016/j.neuroscience.2013.04.057
Petrović, A., Ban, J., Ivaničić, M., Tomljanović, I., and Mladinic, M. (2022). The role of ATF3 in neuronal differentiation and development of neuronal networks in opossum postnatal cortical cultures. Int. J. Mol. Sci. 23:4964. doi: 10.3390/ijms23094964
Seijffers, R., Allchorne, A. J., and Woolf, C. J. (2006). The transcription factor ATF-3 promotes neurite outgrowth. Mol. Cell. Neurosci. 32, 143–154. doi: 10.1016/j.mcn.2006.03.005
Tsujino, H., Kondo, E., Fukuoka, T., Dai, Y., Tokunaga, A., Miki, K., et al. (2000). Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury. Mol. Cell. Neurosci. 15, 170–182. doi: 10.1006/mcne.1999.0814
Weil, Z. M., Norman, G. J., DeVries, A. C., and Nelson, R. J. (2008). The injured nervous system: a darwinian perspective. Prog. Neurobiol. 86, 48–59. doi: 10.1016/j.pneurobio.2008.06.001
Wong, A. W., Osborne, P. B., and Keast, J. R. (2018). Axonal injury induces ATF3 in specific populations of sacral preganglionic neurons in male rats. Front. Neurosci. 12:766. doi: 10.3389/fnins.2018.00766
Yang, T., Zhang, Y., Chen, L., Thomas, E. R., Yu, W., Cheng, B., et al. (2023). The potential roles of ATF family in the treatment of Alzheimer's disease. Biomed. Pharmacother. 161:114544. doi: 10.1016/j.biopha.2023.114544
Yoo, H.-I., Ahn, G.-Y., Lee, E.-J., Kim, E.-g., Hong, S.-Y., Park, S.-J., et al. (2017). 6-Hydroxydopamine induces nuclear translocation of apoptosis inducing factor in nigral dopaminergic neurons in rat. Mol. Cell. Toxicol. 13, 305–315. doi: 10.1007/s13273-017-0034-5
Keywords: ATF3, CNS, nerve injury, apoptosis, neuronal regeneration, axonal injury
Citation: Heinrich R, Aronheim A, Cheng Y-C and Perlman I (2024) Editorial: ATF3: a crucial stress-responsive gene of glia and neurons in CNS. Front. Mol. Neurosci. 17:1484487. doi: 10.3389/fnmol.2024.1484487
Received: 21 August 2024; Accepted: 01 October 2024;
Published: 17 October 2024.
Edited and reviewed by: Jean-Marc Taymans, Institut National de la Santé et de la Recherche Médicale (INSERM), France
Copyright © 2024 Heinrich, Aronheim, Cheng and Perlman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ronit Heinrich, aHJvbml0JiN4MDAwNDA7dGVjaG5pb24uYWMuaWw=